Question Description
In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer? for NEET 2024 is part of NEET preparation. The Question and answers have been prepared according to the NEET exam syllabus. Information about In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer? covers all topics & solutions for NEET 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer?.

Solutions for In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer? in English & in Hindi are available as part of our courses for NEET. Download more important topics, notes, lectures and mock test series for NEET Exam by signing up for free.

Here you can find the meaning of In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer?, a detailed solution for In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer? has been provided alongside types of In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer? theory, EduRev gives you an ample number of questions to practice In gene therapy of Adenosine Deam inase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:a)Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stagesb)Lymphocytes from patients blood are grown in culture, outside the body.c)Genetically engineered lymphocytes are not immortal cells.d)Retroviral vector is introduced into these lymphocytes.Correct answer is option 'C'. Can you explain this answer? tests, examples and also practice NEET tests.